{"organizations": [], "uuid": "fa70e25feb1ab6f6c69f895cd7580c8b92c0322c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180108.html", "section_title": "Archive News &amp; Video for Monday, 08 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-irom-group-unit-signs-ips-cell-tec/brief-irom-group-unit-signs-ips-cell-tech-related-license-agreement-with-q-state-biosciences-idUSL4N1P41Q8", "country": "US", "domain_rank": 408, "title": "BRIEF-I'rom Group unit signs iPS cell tech related license agreement with Q-State Biosciences", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.1, "site_type": "news", "published": "2018-01-09T11:26:00.000+02:00", "replies_count": 0, "uuid": "fa70e25feb1ab6f6c69f895cd7580c8b92c0322c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-irom-group-unit-signs-ips-cell-tec/brief-irom-group-unit-signs-ips-cell-tech-related-license-agreement-with-q-state-biosciences-idUSL4N1P41Q8", "ord_in_thread": 0, "title": "BRIEF-I'rom Group unit signs iPS cell tech related license agreement with Q-State Biosciences", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "id pharma", "sentiment": "negative"}, {"name": "‘rom group co ltd * says co", "sentiment": "neutral"}, {"name": "brief-i'rom group", "sentiment": "neutral"}, {"name": "q-state biosciences inc", "sentiment": "none"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 9 (Reuters) - I‘rom Group Co Ltd\n* Says co’s wholly owned unit ID Pharma signs iPS cell (induced pluripotent stem cell) technology related license agreement with U.S.-based firm Q-State Biosciences Inc\nSource text in Japanese: goo.gl/xfg8so\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/xfg8so"], "published": "2018-01-09T11:26:00.000+02:00", "crawled": "2018-01-09T16:49:38.000+02:00", "highlightTitle": ""}